Ep. 206 Biochemical Recurrence: Insights from AUA/ASTRO/SUO Guidelines with Dr. Todd Morgan

1696.469 - 1717.062 Dr. Todd Morgan

Those patients that have a really late recurrence are at much lower risk of progression. So all those things are important considerations. There is a table in the guideline that lists those key considerations that I just mentioned. I think PSA doubling time is in there too. Genomics can be in there for folks who find genomics to be helpful in their practice. That's kind of the initial framework.